|
HS Code |
536266 |
| Productname | 6-Bromo-4-Methoxyquinoline |
| Casnumber | 29689-98-9 |
| Molecularformula | C10H8BrNO |
| Molecularweight | 238.08 |
| Appearance | Light yellow to beige solid |
| Meltingpoint | 76-80°C |
| Purity | Typically >98% |
| Solubility | Soluble in organic solvents (e.g., DMSO, methanol) |
| Smiles | COC1=CC2=CC=CC=C2N=C1Br |
| Inchi | InChI=1S/C10H8BrNO/c1-13-9-5-8-4-2-3-6-12-10(8)7(9)11 |
As an accredited 6-Bromo-4-Methoxyquinoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-4-Methoxyquinoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry often offers up surprises—and in my experience, specialty compounds like 6-Bromo-4-Methoxyquinoline bring more to the table than many realize at first glance. Researchers and professionals working in synthesis, academia, and industry know that access to reliable, well-characterized intermediates can make or break an entire project timeline. The world of quinolines opens a series of doors for pharmaceutical development, material science, and academic study, drawing from both their unique functional profiles and their adaptability in different synthetic routes. This compound, with the chemical formula C10H8BrNO, has drawn attention for its versatility and the specific outcomes it delivers, especially compared to standard unsubstituted or differently substituted quinolines.
Anyone who has spent time working at the bench knows the difference between running a reaction with high-purity material and gambling on something less. 6-Bromo-4-Methoxyquinoline stands out with its specific array of functional groups arranged across the quinoline backbone. The bromine at position six and methoxy at position four set it apart from similar quinolines; the reason practitioners prize such compounds boils down both to reactivity and control. Methoxy substitution, for instance, can influence electronic distribution across the molecule, while bromine offers a handle for further functionalization through coupling or substitution chemistry. Reliable specifications usually mean melting point, spectral confirmation by NMR and IR, and strict limits on trace impurities—all of which impact reaction reliability and reproducibility. For people who have spent nights troubleshooting mysteries in reaction yields, those quality markers are essential, not decorative.
The story of 6-Bromo-4-Methoxyquinoline goes well beyond theory. Among those engaged with chemical synthesis, this molecule often acts as a starting material or intermediate for more advanced targets. In the lab, the presence of a bromine atom offers a direct entry point for Suzuki and Buchwald-Hartwig cross-coupling reactions. This feature matters a great deal: late-stage modification of quinoline scaffolds often saves weeks on a synthetic route, cutting down on purification headaches and increasing the likelihood of success in scaling up. The methoxy group doesn't just add bulk; it has the potential to steer selectivity, affecting not only the reactivity profile but also purification efficiency. Specialty pharmaceutical intermediates often share common ancestors like 6-Bromo-4-Methoxyquinoline, allowing researchers to create tailored analogues of bioactive frameworks such as antimalarial, antibacterial, or kinase inhibitor candidates. Plenty of published work references the use of this molecule when targeting quinoline-based pharmacophores, especially when seeking single-site variation in structure-activity investigations.
From what I've encountered, reliable sourcing can be every bit as important as the chemistry itself. High-grade 6-Bromo-4-Methoxyquinoline typically comes as a solid, off-white to light yellow in color, with clearly defined batch quality metrics, including chromatographic purity, moisture content, and residual solvent checks. Handling tends not to be especially challenging by the standards of fine organic molecules, though as with most bromo derivatives, proper protective measures and ventilation are the norm. Having access to compound-specific data such as precise melting point or NMR traces builds trust not only for compliance—say, in regulated discovery settings—but, crucially, in delivering consistent results from batch to batch. In the world of medicinal chemistry, that level of predictability translates to fewer surprises downstream.
Chemists often compare 6-Bromo-4-Methoxyquinoline with analogues—some with chloro, fluoro, or different substituents at various ring positions. It’s clear to me that the specific arrangement here offers unique advantages. While chloro or fluoro derivatives might display distinct reactivity or toxicity profiles, the bromine introduces a robust hook for transformations without the stubbornness sometimes seen with chloro substituents. Methoxy groups influence solubility and electron density, which can have dramatic effects downstream in both biological screening and process chemistry. For my colleagues aiming to build or modify complex heterocycles, this combination tends to balance reactivity with predictability. Smaller, simpler quinolines are more limiting for late transformations, forcing additional steps that eat into both time and material costs. Here, 6-Bromo-4-Methoxyquinoline provides a single, reliable hub for further innovation, cutting out avoidable workarounds and helping move new ideas toward practical application.
A closer look at the literature reveals a solid foundation for this compound. Studies have leveraged 6-Bromo-4-Methoxyquinoline as a precursor for antimalarial research, particularly in the development of novel analogues of chloroquine and related drugs. The ability to append diverse groups at the bromine position or modulate the electronic environment at the methoxy site translates to more potent structure-activity relationships. That means not only faster progress but also cleaner data in high-throughput settings. In materials chemistry and luminescent studies, quinoline derivatives with these sorts of substitutions can yield unusual optical properties, supporting advances in organic electronics and dye development. From what I’ve seen, research groups across academia and industry return to this compound as a trusted starting point for projects that deal in both depth and breadth of innovation.
Consistency can slip through the cracks when dealing with specialty chemicals, especially as projects scale or move between different facilities. In my own projects, minor shifts in impurity profiles or physical form have led to frustrating setbacks. Maintaining a narrow specification window—often under 98 percent purity by HPLC, with closely monitored moisture and residual heavy metals—accounts for many pitfalls. Communicating directly with reputable suppliers, requesting full analytic profiles, and running periodic check analyses in-house form the backbone of a smooth workflow. While some might see these steps as time-consuming, the return in reliability far outweighs the upfront investment. In larger-scale settings, securing documentation of batch-to-batch equivalency keeps the risk of downstream troubleshooting to a minimum.
Transitioning from bench-scale experimentation to pilot plant operations surfaces its own set of issues. 6-Bromo-4-Methoxyquinoline benefits from reasonably stable handling properties, but packaging and transport bring new concerns, especially around moisture uptake, caking, or contamination. Investing in robust packaging—such as sealed, inert-gas filled containers for larger lots—has saved both material and frustration. For those navigating regulatory requirements or GMP environments, transparent supply chain documentation for each batch, complete with analytical data and traceability, makes approval or scale-up smoother and less fraught. It’s worth noting that while 6-Bromo-4-Methoxyquinoline's basic storage and handling don't create unusual hazards compared to many aromatic bromo compounds, due diligence always pays off in time saved and wasted effort avoided.
One lesson from years spent handling specialty reagents is this: analytics aren't just paperwork. Modern laboratories rely on high-resolution NMR, mass spectrometry, and elemental analysis to confirm identity and purity. Infrared spectra reveal subtle impurities no eye can detect, where a missing signal can help dodge a future synthetic setback. For 6-Bromo-4-Methoxyquinoline, close attention to spectral fingerprints helps catch vendor cross-contamination, batch inconsistencies, or the rare but conversation-halting instance of isomeric impurities. Anyone working to defend their results, whether publishing or advancing toward regulatory submission, benefits from this level of diligence.
This isn't just about ticking boxes; real projects stall or succeed depending on traceable, transparent supply lines. Laboratories demand more than raw material; they want detailed information on origins, purification methods, and stability checks—without those, troubleshooting late in a process becomes exponentially harder. Many researchers learn after hard experience to demand COAs, external quality certifications, and shipping condition confirmation, particularly for time-sensitive medicinal chemistry campaigns. This has been as relevant for start-up biotech projects as it is for large pharma teams.
Developers following green chemistry initiatives increasingly scrutinize the intermediate chemicals running through their pipelines. 6-Bromo-4-Methoxyquinoline, though not without its environmental footprint, tends to offer less toxic byproducts than heavier halogenated systems. The presence of bromine does require thoughtful disposal and waste management, but the absence of more persistent or bioaccumulative halogens pays dividends over a process lifecycle. Pursuing chemical suppliers who can verify responsible waste treatment upstream and provide clear documentation supports not just compliance but long-term risk planning.
From my own projects, a few best practices rise to the top for making the most out of 6-Bromo-4-Methoxyquinoline. Always confirm the material upon arrival, running your own set of checks to rule out degradation or transit contamination. Store it in airtight, desiccator conditions in opaque containers to prevent both moisture pickup and photodegradation. At the bench, solubilize in dry, inert-solvent systems, as trace water or reactive co-solvents can cause hydrolysis or deactivation during scale-up. Most synthetic protocols involving this compound recommend standard glove or fume hood protection, especially as dust inhalation or prolonged skin contact shouldn’t be overlooked even with substances viewed as ‘routine.’ Small investments in analytic confirmation and safe handling pay for themselves several times over.
Thinking about where the next breakthroughs might surface, I see this compound remaining a steady contributor to medicinal chemistry, advanced materials, and process optimization efforts. Researchers interested in exploring new regions of chemical space often start with molecular platforms that combine functional diversity, manageable reactivity, and robust analytics. 6-Bromo-4-Methoxyquinoline checks these boxes, setting a stable foundation for peptide conjugation, bioisosteric modifications, or creation of light-emitting scaffolds for analytical sensors. In academic environments, its use as a building block for upper-level teaching laboratories introduces future chemists to real-world complexity with a reasonable safety margin. More teams now recognize the return on early investment in robust, well-characterized intermediates—not only do they drive innovation, but they also minimize time lost on revisiting synthesis fundamentals.
Nothing substitutes for the practical proof that comes from real-world comparison. Among similar quinoline derivatives, 6-Bromo-4-Methoxyquinoline wins points for its specific blend of reactivity and ease of downstream manipulation. Reactions that falter or stall with chloro or iodo analogues tend to run more smoothly with bromo, thanks to a sweet spot in bond strength and leaving group ability. Methoxy substitution at the four-position doesn't just tweak reactivity; it also introduces favourable shifts in polarity that can simplify both extraction and chromatographic separation. Colleagues working on kinase inhibitors, OLED materials, or advanced dye chemistry all find use for these properties, often looping back to this intermediate as a trusted launching pad. With every successful campaign, confidence in its performance grows.
Synthetic chemistry keeps advancing, and the expectations for every building block shift accordingly. The increased drive toward sustainable, cost-effective, and rapid discovery cycles means intermediates like 6-Bromo-4-Methoxyquinoline need to deliver on multiple fronts—predictable reactivity, reliable supply, and straightforward analytical verification. Teams working on small-molecule drugs, scalable electronic devices, or highly selective catalysts each depend on intermediates that can bridge bench and pilot plant requirements. Over the years, my experience has shown that compounds like this—rooted in well-established literature, supported by transparent analytics, and validated in both small and large-scale projects—form an indispensable part of that future.
Modern research, whether academic or industrial, doesn't leave much room for uncertainty. The expectations for traceability, purity, and documentation only rise each year—trends driven by both external regulators and by the internal demands of larger research teams stretching toward more complicated targets. Choosing to work with well-characterized intermediates, and demanding detailed specifications from suppliers, leads to smoother internal workflows and more convincing research outcomes. It’s a lesson that has been reinforced through plenty of hands-on struggles with suboptimal materials: rigor up front leads to fewer headaches at every stage, from exploratory work right through to product submission or publication.
As the sector continues to evolve, better supply chain partnerships and deeper in-house analytics combine to create best-in-class workflows. Leveraging compounds like 6-Bromo-4-Methoxyquinoline for research, process development, or teaching means keeping sight of these evolving standards while staying grounded in day-to-day realities. Close relationships with trusted suppliers, openness to new analytic technologies, and persistent focus on documentation form the trio that keeps projects not just on track, but ahead. Wherever chemistry explores next, the central role of proven, adaptable intermediates stays clear. Here, 6-Bromo-4-Methoxyquinoline’s established reliability and versatility place it in a position of ongoing value, supporting both today’s goals and tomorrow’s innovations.